nach oben

European Journal of Pediatrics

Erschienen in:

11.06.2021 | Review

Association between neonatal hyperglycemia and retinopathy of prematurity: a meta-analysis

verfasst von: Chunyan Lei, Jianan Duan, Ge Ge, Meixia Zhang

Erschienen in: European Journal of Pediatrics | Ausgabe 12/2021

Einloggen, um Zugang zu erhalten

Abstract

Through a meta-analysis, we aimed to investigate whether neonatal hyperglycemia was associated with an increased risk of retinopathy of prematurity (ROP) by summarizing all available observational evidence. We searched online databases for studies published prior to December 2020; 26745 neonates with 3227 cases of ROP in 11 case–control studies and 997 neonates with 496 cases of hyperglycemia in 5 cohort studies were included. The results showed that the association between hyperglycemia and the occurrence of ROP was statistically significant in case–control studies (OR 3.93, 95% CI 2.36–6.53) and cohort studies (OR 1.70, 95% CI 1.11–2.60). Besides, the borderline significant association between the duration of hyperglycemia and ROP was observed in case–control studies (MD = 1.96, 95% CI 0.90–3.03; adjusted OR = 1.08, 95% CI 1.01–1.15). Furthermore, we found that the mean blood glucose level is higher in the ROP group than the non-ROP group in case–control studies (MD = 14.86, 95% CI 5.06–24.66) and the mean blood glucose level is higher in the hyperglycemia group than in the non-hyperglycemia group (MD = 86.54, 95% CI 11.03–162.05). However, after adjusting other confounders, the association between the mean blood glucose level and ROP varied in cohort studies (OR 1.96, 95% CI 1.23–3.13) and case–control studies (OR 1.02, 95% CI 1.00–1.05).

Conclusion: This meta-analysis demonstrates that preterm infants with hyperglycemia have a tendency to increase the risk of ROP. Further studies will be required to achieve a firm conclusion for hyperglycemia and ROP and promote a better understanding of the prevention of ROP.

Trial registration: CRD42021228733

What is Known: • Hyperglycemia including the duration and daily mean blood glucose concentration has been associated with the risk of developing ROP in some clinical studies. Current evidence cannot reach a consensus on whether neonatal hyperglycemia is a risk factor for ROP.
What is New: • This meta-analysis demonstrates that preterm infants with hyperglycemia have a tendency to increase the risk of ROP. • While the association between the mean blood glucose level and ROP remains inconclusive.

Nur mit Berechtigung zugänglich

Hartnett ME, Penn JS (2012) Mechanisms and management of retinopathy of prematurity. N Engl J Med 367:2515–2526. https://doi.org/10.1056/NEJMra1208129CrossRefPubMedPubMedCentral

Lad EM, Hernandez-Boussard T, Morton JM, Moshfeghi DM (2009) Incidence of retinopathy of prematurity in the United States: 1997 through 2005. Am J Ophthalmol 148:451–458. https://doi.org/10.1016/j.ajo.2009.04.018CrossRefPubMed

Sapieha P, Joyal JS, Rivera JC, Kermorvant-Duchemin E, Sennlaub F, Hardy P, Lachapelle P, Chemtob S (2010) Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life. J Clin Invest 120:3022–3032. https://doi.org/10.1172/JCI42142CrossRefPubMedPubMedCentral

Hellstrom A, Smith LE, Dammann O (2013) Retinopathy of prematurity. Lancet 382:1445–1457. https://doi.org/10.1016/S0140-6736(13)60178-6CrossRefPubMedPubMedCentral

Beardsall K, Vanhaesebrouck S, Ogilvy-Stuart AL, Vanhole C, Palmer CR, Van Weissenbruch M, Midgley P, Thompson M, Thio M, Cornette L, Ossuetta I, Iglesias I, Theyskens C, De Jong M, Ahluwalia JS, De Zegher F, Dunger DB (2008) Early insulin therapy in very-low-birth-weight infants. N Engl J Med 359:1873–1884. https://doi.org/10.1056/NEJMoa0803725CrossRefPubMed

Ertl T, Gyarmati J, Gaal V, Szabo I (2006) Relationship between hyperglycemia and retinopathy of prematurity in very low birth weight infants. Biol Neonate 89:56–59. https://doi.org/10.1159/000088199CrossRefPubMed

Blanco CL, Baillargeon JG, Morrison RL, Gong AK (2006) Hyperglycemia in extremely low birth weight infants in a predominantly Hispanic population and related morbidities. J Perinatol 26:737–741. https://doi.org/10.1038/sj.jp.7211594CrossRefPubMed

Garg R, Agthe AG, Donohue PK, Lehmann CU (2003) Hyperglycemia and retinopathy of prematurity in very low birth weight infants. J Perinatol 23:186–194. https://doi.org/10.1038/sj.jp.7210879CrossRefPubMed

Mohsen L, Abou-Alam M, El-Dib M, Labib M, Elsada M, Aly H (2014) A prospective study on hyperglycemia and retinopathy of prematurity. J Perinatol 34:453–457. https://doi.org/10.1038/jp.2014.49CrossRefPubMed

10.

Mohamed S, Murray JC, Dagle JM, Colaizy T (2013) Hyperglycemia as a risk factor for the development of retinopathy of prematurity. BMC Pediatr 13. https://doi.org/10.1186/1471-2431-13-78

11.

Slidsborg C, Jensen LB, Rasmussen SC, Fledelius HC, Greisen G, De La Cour M (2018) Early postnatal hyperglycaemia is a risk factor for treatment-demanding retinopathy of prematurity. Br J Ophthalmol 102:14–18. https://doi.org/10.1136/bjophthalmol-2016-309187CrossRefPubMed

12.

Fu Z, Lofqvist CA, Liegl R, Wang Z, Sun Y, Gong Y, Liu CH, Meng SS, Burnim SB, Arellano I, Chouinard MT, Duran R, Poblete A, Cho SS, Akula JD, Kinter M, Ley D, Pupp IH, Talukdar S, Hellstrom A, Smith LE (2018) Photoreceptor glucose metabolism determines normal retinal vascular growth. EMBO Mol Med 10:76–90. https://doi.org/10.15252/emmm.201707966CrossRefPubMed

13.

Kermorvant-Duchemin E, Pinel AC, Lavalette S, Lenne D, Raoul W, Calippe B, Behar-Cohen F, Sahel JA, Guillonneau X, Sennlaub F (2013) Neonatal hyperglycemia inhibits angiogenesis and induces inflammation and neuronal degeneration in the retina. PLoS One 8:e79545. https://doi.org/10.1371/journal.pone.0079545CrossRefPubMedPubMedCentral

14.

Chavez-Valdez R, Mcgowan J, Cannon E, Lehmann CU (2011) Contribution of early glycemic status in the development of severe retinopathy of prematurity in a cohort of ELBW infants. J Perinatol 31:749–756. https://doi.org/10.1038/jp.2011.19CrossRefPubMed

15.

Au SCL, Tang SM, Rong SS, Chen LJ, Yam JCS (2015) Association between hyperglycemia and retinopathy of prematurity: a systemic review and meta-analysis. Sci Rep 5:9091. https://doi.org/10.1038/srep09091CrossRefPubMedPubMedCentral

16.

Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605. https://doi.org/10.1007/s10654-010-9491-zCrossRef

17.

Kwon BK, Roffey DM, Bishop PB, Dagenais S, Wai EK (2011) Systematic review: occupational physical activity and low back pain. Occup Med (Lond) 61:541–548. https://doi.org/10.1093/occmed/kqr092CrossRef

18.

Bozdag S, Oguz SS, Gokmen T, Tunay Z, Tok L, Uras N, Erdeve O, Dilmen U (2011) Serum fructosamine and retinopathy of prematurity. Indian J Pediatr 78:1503–1509. https://doi.org/10.1007/s12098-011-0515-9CrossRefPubMed

19.

Ahmadpour-Kacho M, Motlagh AJ, Rasoulinejad SA, Jahangir T, Bijani A, Pasha YZ (2014) Correlation between hyperglycemia and retinopathy of prematurity. Pediatr Int 56:726–730. https://doi.org/10.1111/ped.12371CrossRefPubMed

20.

Van Der Merwe SK, Freeman N, Bekker A, Harvey J, Smith J (2013) Prevalence of and risk factors for retinopathy of prematurity in a cohort of preterm infants treated exclusively with non-invasive ventilation in the first week after birth. S Afr Med J 103:96–101. https://doi.org/10.7196/SAMJ.6131CrossRefPubMed

21.

Nicolaeva GV, Sidorenko EI, Iosifovna AL (2015) Influence of the blood glucose level on the development of retinopathy of prematurity in extremely premature children. Arq Bras Oftalmol 78:232–235. https://doi.org/10.5935/0004-2749.20150060CrossRefPubMed

22.

Lee JH, Hornik CP, Testoni D, Laughon MM, Cotten CM, Maldonado RS, Belcastro MR, Clark RH, Smith PB (2016) Insulin, hyperglycemia, and severe retinopathy of prematurity in extremely low-birth-weight infants. Am J Perinatol 33:393–400. https://doi.org/10.1055/s-0035-1565999CrossRefPubMed

23.

Mutangana F, Muhizi C, Mudereva G, Noë P, Musiime S, Ngambe T, Tuyisenge L, Kumwami M, Nsabimana H, Conard C, Fonteyne Y, Casteels I, De Smedt S, Cannoodt L, Casteels I, Conard C, De Smedt S, Devlieger H, Fonteyne Y, Gilbert C, Gisagara E, Kumwami M, Mudereva G, Muhizi C, Mulindwa Karemazi G, Musiime S, Mutangana F, Mutsinzi E, Ngambe T, Noë P, Nsabimana H, Nyemazi A, Sebuseruka S, Tuyisabe T, Tuyisenge L, Uwurukundo MC, Van Kerschaver E (2019) Retinopathy of prematurity in Rwanda: a prospective multi-centre study following introduction of screening and treatment services. Eye (Basingstoke) 34:847–856. https://doi.org/10.1038/s41433-019-0529-5CrossRef

24.

Kaempf JW, Kaempf AJ, Wu Y, Stawarz M, Niemeyer J, Grunkemeier G (2011) Hyperglycemia, insulin and slower growth velocity may increase the risk of retinopathy of prematurity. J Perinatol 31:251–257. https://doi.org/10.1038/jp.2010.152CrossRefPubMed

25.

Heimann K, Peschgens T, Kwiecien R, Stanzel S, Hoernchen H, Merz U (2007) Are recurrent hyperglycemic episodes and median blood glucose level a prognostic factor for increased morbidity and mortality in premature infants ≤ 1500 g? J Perinat Med 35:245–248. https://doi.org/10.1515/JPM.2007.057CrossRefPubMed

26.

Sabzehei MK, Afjeh SA, Shakiba M, Alizadeh P, Shamshiri AR, Esmaili F (2014) Hyperglycemia in VLBW infants; incidence, risk factors, and outcome. Arch Iran Med 17:429–434PubMed

27.

Leung M, Black J, Bloomfield FH, Gamble GD, Harding JE, Jiang Y, Poppe T, Thompson B, Tottman AC, Wouldes TA, Alsweiler JM, Group PS (2020) Effects of neonatal hyperglycemia on retinopathy of prematurity and visual outcomes at 7 years of age: a matched cohort study. J Pediatr 223(42-50):42–50.e2. https://doi.org/10.1016/j.jpeds.2020.04.059CrossRefPubMed

28.

Kim NH, Jung HH, Cha DR, Choi DS (2000) Expression of vascular endothelial growth factor in response to high glucose in rat mesangial cells. J Endocrinol 165:617–624. https://doi.org/10.1677/joe.0.1650617CrossRefPubMed

29.

Brooks SE, Gu X, Kaufmann PM, Marcus DM, Caldwell RB (1998) Modulation of VEGF production by pH and glucose in retinal Muller cells. Curr Eye Res 17:875–882. https://doi.org/10.1076/ceyr.17.9.875.5134CrossRefPubMed

30.

Beardsall K, Vanhaesebrouck S, Frystyk J, Ogilvy-Stuart AL, Vanhole C, Van Weissenbruch M, Midgley P, Thio M, Cornette L, Gill B, Ossuetta I, Iglesias I, Theyskens C, De Jong M, Ahluwalia JS, De Zegher F, Dunger DB, Group NS (2014) Relationship between insulin-like growth factor I levels, early insulin treatment, and clinical outcomes of very low birth weight infants. J Pediatr 164:1038–1044.e1. https://doi.org/10.1016/j.jpeds.2013.12.046CrossRefPubMed

31.

Cakir B, Hellstrom W, Tomita Y, Fu Z, Liegl R, Winberg A, Hansen-Pupp I, Ley D, Hellstrom A, Lofqvist C, Smith LE (2020) IGF1, serum glucose, and retinopathy of prematurity in extremely preterm infants. JCI Insight 5:e140363. https://doi.org/10.1172/jci.insight.140363

32.

Kermorvant-Duchemin E, Le Meur G, Plaisant F, Marchand-Martin L, Flamant C, Porcher R, Lapillonne A, Chemtob S, Claris O, Ancel PY, Rozé JC (2020) Thresholds of glycemia, insulin therapy, and risk for severe retinopathy in premature infants: a cohort study. PLoS Med 17:e1003477. https://doi.org/10.1371/journal.pmed.1003477CrossRefPubMedPubMedCentral

33.

Meetze W, Bowsher R, Compton J, Moorehead H (1998) Hyperglycemia in extremely-low-birth-weight infants. Biol Neonate 74:214–221. https://doi.org/10.1159/000014027CrossRefPubMed

34.

Alsweiler JM, Harding JE, Bloomfield FH (2012) Tight glycemic control with insulin in hyperglycemic preterm babies: a randomized controlled trial. Pediatrics 129:639–647. https://doi.org/10.1542/peds.2011-2470CrossRefPubMed

35.

Beardsall K, Ogilvy-Stuart AL, Frystyk J, Chen JW, Thompson M, Ahluwalia J, Ong KK, Dunger DB (2007) Early elective insulin therapy can reduce hyperglycemia and increase insulin-like growth factor-I levels in very low birth weight infants. J Pediatr 151:611–617.e1. https://doi.org/10.1016/j.jpeds.2007.04.068CrossRefPubMed

36.

Vanhaesebrouck S, Vanhole C, Theyskens C, Casteels I, Maleux J, Allegaert K, Naulaers G, Daniëls H, De Zegher F (2012) Continuous glucose monitoring and retinopathy of prematurity. Eur J Ophthalmol 22:436–440. https://doi.org/10.5301/ejo.5000052CrossRefPubMed

37.

Perri A, Sbordone A, Patti ML, Tiberi E, Vento G (2021) Continuous glucose monitoring in the neonatal intensive care unit: need for practical guidelines. Lancet Child Adolesc Health 5:e15. https://doi.org/10.1016/S2352-4642(21)00096-1CrossRefPubMed

38.

Beardsall K, Thomson L, Guy C, Iglesias-Platas I, Van Weissenbruch MM, Bond S, Allison A, Kim S, Petrou S, Pantaleo B, Hovorka R, Dunger D, Collaborative R (2021) Real-time continuous glucose monitoring in preterm infants (REACT): an international, open-label, randomised controlled trial. Lancet Child Adolesc Health 5:265–273. https://doi.org/10.1016/S2352-4642(20)30367-9CrossRefPubMedPubMedCentral

Titel: Association between neonatal hyperglycemia and retinopathy of prematurity: a meta-analysis
verfasst von: Chunyan Lei
Jianan Duan
Ge Ge
Meixia Zhang
Publikationsdatum: 11.06.2021
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Pediatrics / Ausgabe 12/2021
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI: https://doi.org/10.1007/s00431-021-04140-w

Neu im Fachgebiet Pädiatrie

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

16.05.2024 Arterielle Hypertonie in der Pädiatrie Nachrichten

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Association between neonatal hyperglycemia and retinopathy of prematurity: a meta-analysis

Abstract

Neu im Fachgebiet Pädiatrie

ADHS-Medikation erhöht das kardiovaskuläre Risiko

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

Update Pädiatrie

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2021

The use of thromboelastography (TEG) and rotational thromboelastometry (ROTEM) in neonates: a systematic review

Macronutrient analysis of human milk and factors associated with its composition in mothers of preterm infants ≤ 32 weeks

Outcomes in Hirschsprung’s disease with coexisting learning disability

The evolution of cardiac point of care ultrasound for the neonatologist

Non-antibiotic interventions for prevention of urinary tract infections in children: a systematic review and meta-analysis of randomized controlled trials

Review of eosinophilic oesophagitis in children and young people

Neu im Fachgebiet Pädiatrie

ADHS-Medikation erhöht das kardiovaskuläre Risiko

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

Update Pädiatrie